glp-1 news oct 21 2025 In U.S., Usage Reaches New High Patients Face New Barriers for

Agerelated declines of 13 % per year in GH, melatonin, and cortisol further underscore the need for targeted interventions

GLP-1 medications may be recommended for: People with type 2 diabetes who need better blood sugar control

Disrupted circadian clock rhythm has been recognized as one of the causes of metabolic syndrome and metabolic syndrome-induced cancers 6,7,8

ALOX15-launched PUFA-phospholipids peroxidation increases the susceptibility of ferroptosis in ischemia-induced myocardial damage

IGF-1 inhibits cartilage catabolism When OA occurs, the ECM, especially type II collagen and aggrecan, is degraded

Each product undergoes rigorous clinical testing before being released into the market